Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: CPAMarty who wrote (244)	1/24/1999 5:16:00 PM
From: CPAMarty	Respond to of 2515

Maybe it would make sense for Imclone to participate in something like this zdii.com

To: CPAMarty who wrote (244)	2/11/1999 7:51:00 AM
From: Jim Oravetz	Read Replies (1) \| Respond to of 2515

Inside Track Numerous Biotechnology Executives Purchase Shares of Their Ailing Stocks By DANIELLE SESSA Staff Reporter of THE WALL STREET JOURNAL Some executives at biotechnology companies, taking their own medicine, are snapping up shares of their ailing stocks. Since late last year, ImClone Systems Inc., Cell Therapeutics Inc., Gene Logic Inc. and Organogenesis Inc. have all seen their insiders dig into their pockets and buy company stock. ...... Message 7770833